Covered recipient · General Payments record
JACQUELINE S GARCIA
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$51,644.97
- Reported across 57 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $12,200.00 | 5 |
| Food and Beverage | $433.69 | 4 |
| Travel and Lodging | $240.50 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $8,390.50 | 7 |
| Acerta Pharma LLC | $4,235.00 | 2 |
| Abbott Laboratories | $178.22 | 1 |
| Kite Pharma, Inc. | $70.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $178.22 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134594307 | CMS |
| ABBVIE INC. | $4,050.00 | 01/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103134605 | CMS |
| ABBVIE INC. | $210.01 | 01/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104186106 | CMS |
| ABBVIE INC. | $1,350.00 | 01/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103134607 | CMS |
| ABBVIE INC. | $30.49 | 01/25/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104186108 | CMS |
| ABBVIE INC. | $1,350.00 | 03/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103134609 | CMS |
| ABBVIE INC. | $1,350.00 | 03/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103134611 | CMS |
| ABBVIE INC. | $50.00 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103773576 | CMS |
| AstraZeneca Pharmaceuticals LP | $135.00 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104230497 | CMS |
| AstraZeneca Pharmaceuticals LP | $4,100.00 | 12/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104303598 | CMS |
| Kite Pharma, Inc. | $70.47 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128609323 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.